Diagnosis and Management of Autoimmune Pancreatitis

Gastroenterology Clinics of North America

Volumn 41, Issue 1, 2012, Pages 9-22

  Sugumar, Aravind ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Idiopathic duct centric pancreatitis; IgG4; Lymphoplasmacytic sclerosing pancreatitis; Pancreatic cancer

Indexed keywords

AZATHIOPRINE; CA 19-9 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN G4; PREDNISONE;

ABDOMINAL PAIN; ASPIRATION BIOPSY; AUTOIMMUNE PANCREATITIS; AUTOIMMUNE PANCREATITIS TYPE 1; AUTOIMMUNE PANCREATITIS TYPE 2; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE PANCREATOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTIC INFILTRATION; MAINTENANCE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS DUCT; PANCREATOGRAPHY; PATHOPHYSIOLOGY; RELAPSE; REVIEW; SERODIAGNOSIS; SYMPTOM; TREATMENT DURATION;

ALGORITHMS; AUTOIMMUNE DISEASES; HUMANS; PANCREATITIS;

EID: 84857067064     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.12.008     Document Type: Review

References (80)

1. Sarles H., Sarles J.C., Muratore R., et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease?. Am J Dig Dis 1961, 6:688-698.
2. Yoshida K., Toki F., Takeuchi T., et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40(7):1561-1568.
3. Chutaputti A., Burrell M.I., Boyer J.L. Pseudotumor of the pancreas associated with retroperitoneal fibrosis: a dramatic response to corticosteroid therapy. Am J Gastroenterol 1995, 90(7):1155-1158.
4. Sood S., Fossard D.P., Shorrock K. Chronic sclerosing pancreatitis in Sjogren's syndrome: a case report. Pancreas 1995, 10(4):419-421.
5. Horiuchi A., Kaneko T., Yamamura N., et al. Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol 1996, 91(12):2607-2609.
6. Chari S.T., Smyrk T.C., Levy M.J., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4(8):1010-1016.
7. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344(10):732-738.
8. Kamisawa T., Egawa N., Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003, 98(12):2811-2812.
9. Kamisawa T., Funata N., Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol 2004, 28(8):1114.
10. Kawaguchi K., Koike M., Tsuruta K., et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991, 22(4):387-395.
11. Ectors N., Maillet B., Aerts R., et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997, 41(2):263-268.
12. Kazumori H., Ashizawa N., Moriyama N., et al. Primary sclerosing pancreatitis and cholangitis. Int J Pancreatol 1998, 24(2):123-127.
13. Petter L.M., Martin J.K., Menke D.M. Localized lymphoplasmacellular pancreatitis forming a pancreatic inflammatory pseudotumor. Mayo Clin Proc 1998, 73(5):447-450.
14. Sugumar A., Chari S. Autoimmune pancreatitis: an update. Expert Rev Gastroenterol Hepatol 2009, 3(2):197-204.
15. Sugumar A., Kloppel G., Chari S.T. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol 2009, 104(9):2308-2310. [quiz 11].
16. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40(3):352-8.
17. Chari S.T., Kloeppel G., Zhang L., et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 2010, 39(5):549-554.
18. Zhang L., Chari S., Smyrk T.C., et al. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 2011, 40(8):1172-1179.
19. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004, 29(2):167-168.
20. Zen Y., Harada K., Sasaki M., et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?. Am J Surg Pathol 2004, 28(9):1193-1203.
21. Okazaki K., Uchida K., Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol 2008, 43(6):409-418.
22. Deshpande V., Chicano S., Finkelberg D., et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006, 30(12):1537-1545.
23. Kloppel G., Luttges J., Lohr M., et al. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003, 27(1):14-19.
24. Yadav D., Notahara K., Smyrk T.C., et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol 2003, 1(2):129-135.
25. Zamboni G., Luttges J., Capelli P., et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004, 445(6):552-563.
26. Sugumar A., Chari S.T. Autoimmune pancreatitis. J Gastroenterol Hepatol 2011, 26(9):1368-1373.
27. Kim K.P., Kim M.H., Song M.H., et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004, 99(8):1605-1616.
28. Kojima E., Kimura K., Noda Y., et al. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003, 38(6):603-607.
29. Ito T., Nakano I., Koyanagi S., et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997, 42(7):1458-1468.
30. Kawa S., Ota M., Yoshizawa K., et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002, 122(5):1264-1269.
31. Park do H., Kim M.H., Oh H.B., et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008, 134(2):440-446.
32. Kountouras J., Zavos C., Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 2005, 9(1):196-207.
33. Kountouras J., Zavos C., Gavalas E., et al. Challenge in the pathogenesis of autoimmune pancreatitis: potential role of Helicobacter pylori infection via molecular mimicry. Gastroenterology 2007, 133(1):368-369.
34. Vlug A., Nieuwenhuys E.J., van Eijk R.V., et al. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin [Paris] 1994, 52(7-8):561-567.
35. van der Zee J.S., van Swieten P., Aalberse R.C. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 1986, 64(2):415-422.
36. Aalberse R.C., Van Milligen F., Tan K.Y., et al. Allergen-specific IgG4 in atopic disease. Allergy 1993, 48(8):559-569.
37. Hussain R., Poindexter R.W., Ottesen E.A. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 1992, 148(9):2731-2737.
38. Shirakata Y., Shiraishi S., Sayama K., et al. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol 1990, 17(11):661-666.
39. Ljungstrom I., Hammarstrom L., Kociecka W., et al. The sequential appearance of IgG subclasses and IgE during the course of Trichinella spiralis infection. Clin Exp Immunol 1988, 74(2):230-235.
40. Ghazale A., Chari S.T., Smyrk T.C., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007, 102(8):1646-1653.
41. Ghazale A., Chari S.T., Zhang L., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134(3):706-715.
42. Raina A., Yadav D., Krasinskas A.M., et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009, 104(9):2295-2306.
43. Zhang L., Notohara K., Levy M.J., et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007, 20(1):23-28.
44. Smith C.D., Behrns K.E., van Heerden J.A., et al. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 1994, 81(4):585-589.
45. Nishimori I., Tamakoshi A., Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007, 42(Suppl 18):6-8.
46. Sah R.P., Pannala R., Chari S.T., et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010, 8(1):91-96.
47. Kamisawa T., Shimosegawa T., Okazaki K., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009, 58(11):1504-1507.
48. Nishimori I., Tamakoshi A., Kawa S., et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas 2006, 32(3):244-248.
49. Kamisawa T., Yoshiike M., Egawa N., et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005, 5(2-3):234-238. discussion 8-40.
50. Chari S.T., Takahashi N., Levy M.J., et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009, 7(10):1097-1103.
51. Irie H., Honda H., Baba S., et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998, 170(5):1323-1327.
52. Kamisawa T., Imai M., Yui Chen P., et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 2008, 37(3):e62-e67.
53. Sugumar A., Chari S.T. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol 2009, 7(11 Suppl):S59-S62.
54. Mikami K., Itoh H. MR imaging of multifocal autoimmune pancreatitis in the pancreatic head and tail: a case report. Magn Reson Med Sci 2002, 1(1):54-58.
55. Ito K., Koike S., Matsunaga N. MR imaging of pancreatic diseases. Eur J Radiol 2001, 38(2):78-93.
56. Kamisawa T., Chen P.Y., Tu Y., et al. MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol 2006, 12(18):2919-2922.
57. Kubota K., Kato S., Akiyama T., et al. A proposal for differentiation between early- and advanced-stage autoimmune pancreatitis by endoscopic ultrasonography. Dig Endosc 2009, 21(3):162-169.
58. Hoki N., Mizuno N., Sawaki A., et al. Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol 2009, 44(2):154-159.
59. Mizuno N., Bhatia V., Hosoda W., et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009, 44(7):742-750.
60. Levy M.J., Smyrk T.C., Takahashi N., et al. Idiopathic duct-centric pancreatitis: disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis. Pancreatology 2011, 11(1):76-80.
61. Dietrich C.F., Hirche T.O., Ott M., et al. Real-time tissue elastography in the diagnosis of autoimmune pancreatitis. Endoscopy 2009, 41(8):718-720.
62. Itokawa F., Itoi T., Sofuni A., et al. EUS elastography combined with the strain ratio of tissue elasticity for diagnosis of solid pancreatic masses. J Gastroenterol 2011, 46(6):843-853.
63. Kamisawa T., Takum K., Anjiki H., et al. FDG-PET/CT findings of autoimmune pancreatitis. Hepatogastroenterology 2010, 57(99-100):447-450.
64. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 60(5):666-70.
65. Raina A., Krasinskas A.M., Greer J.B., et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 2008, 132(1):48-53.
66. Fukukura Y., Fujiyoshi F., Nakamura F., et al. Autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. AJR Am J Roentgenol 2003, 181(4):993-995.
67. Eerens I., Vanbeckevoort D., Vansteenbergen W., et al. Autoimmune pancreatitis associated with primary sclerosing cholangitis: MR imaging findings. Eur Radiol 2001, 11(8):1401-1404.
68. Kamisawa T., Nakajima H., Egawa N., et al. Autoimmune pancreatitis can be confirmed with gastroscopy. Dig Dis Sci 2004, 49(1):155-156.
69. Kamisawa T., Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006, 41(7):613-625.
70. Kamisawa T., Tu Y., Egawa N., et al. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc 2008, 68(2):358-361.
71. Leise M.D., Smyrk T.C., Takahashi N., et al. IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis. Dig Dis Sci 2011, 56(5):1290-1294.
72. Chari S., Murray J.A. Autoimmune pancreatitis Part II: The relapse. Gastroenterology 2008.
73. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J Jpn Pancreas [Suizou] 2002, 17:587. Society MotCCfAPotJP.
74. Okazaki K., Kawa S., Kamisawa T., et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006, 41(7):626-631.
75. Choi E.K., Kim M.H., Lee T.Y., et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007, 35(2):156-161.
76. Otsuki M., Chung J.B., Okazaki K., et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008, 43(6):403-408.
77. Gardner T.B., Chari S.T. Autoimmune pancreatitis. Gastroenterol Clin North Am 2008, 37(2):439-460. vii.
78. Ghazale A., Chari S.T. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007, 56(12):1650-1652.
79. Sandanayake N.S., Church N.I., Chapman M.H., et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009, 7(10):1089-1096.
80. Topazian M., Witzig T.E., Smyrk T.C., et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008, 6(3):364-366.